Viralgen (@ViralgenVC) header
Viralgen (@ViralgenVC) profile picture

All-in on AAV gene therapy manufacturing that empowers innovators to bring more potential cures to more patients

Parque Tecnológico de Gipuzkoa
Joined March 2020
Photo by Viralgen (@ViralgenVC)Photo by Viralgen (@ViralgenVC)Photo by Viralgen (@ViralgenVC)Photo by Viralgen (@ViralgenVC)Photo by Viralgen (@ViralgenVC)Photo by Viralgen (@ViralgenVC)Photo by Viralgen (@ViralgenVC)Photo by Viralgen (@ViralgenVC)Photo by Viralgen (@ViralgenVC)
Some partnerships just make sense. Today we're proud to share that Viralgen is collaborating with #Gene2Cure Foundation, a nonprofit dedicated to advancing gene therapies for children with rare and ultra-rare genetic conditions. Together, we'll be manufacturing a portfolio of investigational #AAV gene therapies using Aava™️, our proprietary platform. As our CEO Jimmy Vanhove puts it: "Collaboration is central to advancing potential gene therapies for rare diseases." We couldn't agree more, and we're looking forward to working alongside the Gene2Cure team. --> Read the full announcement here: viralgen.com/news/gene2cure-… #GeneTherapy #RareDisease #CDMO
14
Some news worth celebrating: Viralgen is now officially @GPTW_Spain Certified™️! 🎉 And the best part is who it comes from: our own team. The people who show up every day to help move promising gene therapies closer to patients, and who make this a place where ideas are shared, people look out for each other, and the science keeps moving forward. (We're taking it as a great reason to celebrate, and an even better reason to keep going.) Thank you to everyone at Viralgen for making it happen. Swipe through to see what our team had to say. #GreatPlaceToWork #GPTWcertified #GeneTherapy #AAV #CDMO
1
34
#AskBio and our subsidiary @ViralgenVC are proud to announce 5 presentations at #ESGCT2026 in Hamburg, October 27–30. Our teams will highlight advancements in AAV manufacturing technologies for gene therapies. Learn more: askbio.com/five-presentation…
1
5
426
The end of the year is always a time of transitions, and for Viralgen, it will come with a notable change. As a part of a planned succession, our CEO Jimmy Vanhove, will be leaving Viralgen after 4 years leading the company for a role within the broader Bayer Pharma network, leading the recently announced network development and expansion into the United States. In his new position, he will join Bayer’s Global Pharma Product Supply Leadership Team. While we are sad to lose him to this new adventure, we are grateful for his years of leadership and wish him continued success in his new chapter. And we look forward to him reporting back on the other kind of football from just outside New Albany, Ohio. At the same time, we are excited to announce his successor, Angela Ochoa, who will assume the role of Viralgen CEO as of January 1, 2027. She comes to us with almost 20 years experience in quality, manufacturing and strategy leadership. At a time when Viralgen is expanding capacity and anticipating multiple commercial launches in the coming months, her leadership and expertise will be an exciting asset for our growth and continued evolution. Welcome, Angela! Ongi etorri! Read the full announcement: viralgen.com/news/viralgen-a…
23
We’re looking forward to seeing you at #ESGCT this year. It’s unique opportunity to make the kinds of connections that drive the future of advanced therapies — including the ones you’re working on right now. Viralgen will have a full team in booths F01 + F08, eager to hear about your development plans, and ready to reach out with ideas for improving the data, increasing the speed and reducing the risk of gene therapy manufacturing. All thanks to Aava™, our proven, high-performance platform. The first step? We’d like to extend an invitation to meet up while you’re at ESGCT. Use the link below to pick a convenient time. viralgen.com/esgct-2026 See you in Hamburg! #ESGCTHamburg2026 #GeneTherapy #AAV #advancedtherapies
166
Viralgen is proud to announce a new collaboration with @EpilepsyGtx to support the development of EPY201, its lead gene therapy programme for focal refractory epilepsy. Through this partnership, #Viralgen will bring its extensive AAV manufacturing expertise and proprietary AAVa™ platform to support the scalable, high-yield production of EPY201 as the programme advances toward first-in-human clinical trials, expected in the first half of 2027. Focal refractory epilepsy remains an area of significant unmet need, and we are pleased to contribute our experience in AAV-based gene therapy manufacturing to help advance a potential new option for people living with this condition. Read the full announcement: viralgen.com/news/epilepsygt… #GeneTherapy #Epilepsy #AAV #FRE
2
69
Viralgen is proud to be the sponsor of this year’s @SETGyC PhD Training Day, focused on using AAVs as delivery vectors for gene editing tools. As a world leader in AAV-based gene therapy manufacturing, it’s a topic that’s near and dear to us. Just as important, we’re excited to get some face time with a new generation of scientists – Cesar Trigueros , Viralgen’s Chief Science Officer, will be a featured speaker in the morning session. We can’t wait to see the creativity and new ideas the attendees bring with them (and put to use in the afternoon design workshop). #AAV #GeneTherapy #RareDiseases #SETGYC
51
Aside from getting safely to Barcelona and greeting friends old and new, Viralgen is focused on just one thing: being a world leader in AAV-based gene therapy manufacturing.   Head of Technical Development & CMC Strategy Jacob Smith and Eero Mustalahti, Business Development Director, will be on hand to show you exactly what that means – from unmatched AAV experience and capacity to Aava™, our high-performance manufacturing platform.     Jacob will also be part of a Tuesday workshop focused on the perils – and more important the possibilities – of scaling advanced therapies.   Have a #genetherapy project in the pipeline? Let’s meet up this week and talk about how Viralgen can help make the process of moving it forward worry-free.  Click to set up a meeting: viralgen.com/schedule-a-meet… Panel: Designing advanced therapies that survive scale: from early decisions to commercial readiness  Tuesday, September 8  13:00 - 14:00 CET Workshop Room (Rossini 1&2) #AdvancedTherapies #CellAndGeneTherapy #ATE2026 @Phacilitate
1
179
𝗙𝗶𝗿𝘀𝘁 𝗕𝗹𝗼𝗼𝗱 𝗗𝗼𝗻𝗮𝘁𝗶𝗼𝗻 𝗮𝘁 𝗩𝗶𝗿𝗮𝗹𝗴𝗲𝗻 🩸 For the first time, Viralgen hosted a #blooddonation initiative and our team showed up! A total of 47 people participated, 𝟯𝟳 𝘄𝗲𝗿𝗲 𝗮𝗯𝗹𝗲 𝘁𝗼 𝗱𝗼𝗻𝗮𝘁𝗲, and 19 donated blood for the very first time. A big thank you to everyone who took part, and to #DonantesdeSangredeEuskadi team from @osakidetzaEJGV for making it possible. We hope this is just the first of many. Every donation matters. Thank you for helping make a difference.
69
Today, the Mayor of Donostia / San Sebastián, @jon_insausti , visited Viralgen together with members of his team, in a meeting that gave us the chance to discuss the city's #development and the #science taking place within it. During the tour, we showed him our GMP labs, where the #genetherapies that reach #patients today are manufactured, and shared how we contribute to driving the sector forward, with the ultimate goal of advancing solutions that can transform patients' lives. We would like to thank the @Ayto_SS for its interest and close engagement, as well as for the opportunity to continue strengthening the dialogue between the institutional, scientific, and industrial ecosystem of our city.
1
1
573
🧪 Berrikuntza eta zientzia, @ViralgenVC-en eskutik ➡️ Viralgen es un claro ejemplo de ciencia, investigación e innovación al servicio de Donostia #Donostia #SanSebastián #Donostiarra
3
6
946
In the first of our multipart “𝐏𝐮𝐥𝐬𝐞 𝐨𝐟 𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬” short-clip interview series, Viralgen and TAAV CEO Jimmy Vanhove explains why he’s optimistic about the progress being made to address #raredisease.  For more on how AAV-based #genetherapy manufacturing is helping advanced therapy innovators reach more patients in more ways, just add the link below to your summer reading list. (And keep an eye out in your feed for our next installment of “Pulse of Progress.”) ➜ viralgen.com #CGT #CellandGenetherapy
68
¡Gracias a @ViralgenVC por abrirnos sus puertas y permitirnos grabar uno de esos procesos que normalmente permanecen lejos de las cámaras!🙌 Un placer descubrir junto a @FPdonboscoLH el trabajo que hay detrás de los avances en terapias génicas 🧬 y la investigación biomédica.🔬
3
3
94
We are excited to welcome Daniel Rivero to Viralgen as our new Head of Manufacturing! Daniel brings extensive leadership experience in global CDMO and pharmaceutical manufacturing operations, with a strong track record in driving growth, operational excellence, and value creation in highly regulated environments. His expertise will be key as we continue to scale our capabilities and deliver high-quality AAV manufacturing solutions to our partners worldwide. 𝗪𝗲𝗹𝗰𝗼𝗺𝗲 𝘁𝗼 𝘁𝗵𝗲 𝘁𝗲𝗮𝗺, 𝗗𝗮𝗻𝗶𝗲𝗹!
54
Hoy, en el #DíaMundialdelMedioAmbiente, cerramos nuestra II Semana de la #Sostenibilidad con una sesión dedicada a uno de los grandes retos ambientales de nuestro tiempo: los plásticos y microplásticos. De la mano de Amaia Orbea del Rey, investigadora y profesora universitaria en EHU, reflexionamos sobre el impacto del uso extensivo del #plástico en el medio ambiente, especialmente en los ecosistemas acuáticos, y sobre la complejidad de encontrar alternativas verdaderamente sostenibles. La sesión nos invitó a mirar más allá de las soluciones aparentemente sencillas y a entender que, también en sostenibilidad, avanzar requiere conocimiento, espíritu crítico y una visión a largo plazo. Gracias, Amaia, por compartir con nosotros una charla tan interesante y necesaria.
104
Viralgen retweeted
🔐La sostenibilidad y la ciberseguridad comparten un mismo objetivo: proteger hoy lo que queremos mantener mañana. Ayer participamos en la II Semana de la Sostenibilidad de @ViralgenVC , donde hablamos sobre IA, resiliencia y los desafíos de la ciberseguridad en el sector salud.
1
1
40
🗣️La directora de #ZIUR, @MariaPenillaA, ha participado en la II Semana de la Sostenibilidad de @Viralgen, abordando algunos de los grandes retos de la #ciberseguridad: #normativas, cadena de suministro, #IA y gestión de equipos IT/Ciber 👏🏻Gracias a @ViralgenVC por la invitación
1
2
41
🗣️@MariaPenillaA #ZIUR-eko zuzendariak parte hartu du @Viralgen-eko Jasangarritasunaren II. Astean, #zibersegurtasuna-ren erronka nagusietako batzuk jorratuz: araudiak, hornidura-katea, #AdimenArtifiziala eta IT/Ziber ekipoen kudeaketa. 👏🏻Eskerrak @ViralgenVC-i gonbidapenagatik!
1
2
54